The Federal Antimonopoly Service (FAS) approved the purchase of several regional pharmacy chains by the Rigla company, according to the agency’s official Telegram channel.
Author:
https://rb.ru/author/ntihonov/
Subscribe to RB.RU on Telegram
The antitrust authority’s report notes that, according to the analysis of the transaction, Rigla LLC will not occupy a dominant position in any of the regions.
The department clarified that we are talking about the purchase of 99.9% of the shares of the authorized capital of the following organizations: Prime-Pharm LLC, Apteka 52 LLC, First Pharmacy LLC, Solo-Pharm LLC, Nizhegorodskaya Pharmacy LLC network”, LLC ” First Pharmacy”, LLC “Pharmacy 24”, LLC “Vita+”, LLC “Pharmacy 78”, LLC “Premier-pharm”, LLC “Prima-pharm”.
Pharmacy chains are located in Moscow and the Moscow region, St. Petersburg, the Republic of Mari El, Nizhny Novgorod, Vladimir, Kaluga and Kirov.
On October 2, the Vedomosti newspaper reported that Rigla, part of Vadim Yakunin’s Protek group, is negotiating the purchase of the combined pharmacy chain Minitsen Pharmacy and Novaya Pharmacy. The agreement may include 282 pharmacies in all constituent entities of the Far Eastern Federal District (except in the Chukotka Autonomous Okrug). One of the publication’s sources clarified that the agreement is in the process of approval by the Federal Antimonopoly Service.
Author:
Nikolai Tikhonov
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
